SAMD12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.575200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.074600E-01
Normal-vs-Stage2
6.173200E-01
Normal-vs-Stage3
4.393800E-01
Normal-vs-Stage4
4.379000E-01
Stage1-vs-Stage2
4.842200E-01
Stage1-vs-Stage3
7.501800E-02
Stage1-vs-Stage4
8.410200E-01
Stage2-vs-Stage3
1.445250E-01
Stage2-vs-Stage4
7.173000E-01
Stage3-vs-Stage4
1.465830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.940800E-01
Normal-vs-AfricanAmerican
5.891600E-01
Normal-vs-Asian
4.796600E-01
Caucasian-vs-AfricanAmerican
7.967400E-01
Caucasian-vs-Asian
4.109200E-01
AfricanAmerican-vs-Asian
7.764800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.875600E-01
Normal-vs-Female
7.665600E-01
Male-vs-Female
2.512200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.898400E-01
Normal-vs-Age(41-60Yrs)
4.689400E-01
Normal-vs-Age(61-80Yrs)
7.699000E-01
Normal-vs-Age(81-100Yrs)
8.104400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.746800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.787600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.186800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.764500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.067400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.897200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.708800E-01
Normal-vs-Daily Drinker
7.475200E-01
Normal-vs-Weekly Drinker
8.943000E-01
Normal-vs-Occasional Drinker
4.095000E-01
Normal-vs-Social Drinker
5.791000E-01
Non Drinker-vs-Daily Drinker
7.549600E-01
Non Drinker-vs-Weekly Drinker
4.370800E-01
Non Drinker-vs-Occasional Drinker
1.950810E-01
Non Drinker-vs-Social Drinker
8.531000E-01
Daily Drinker-vs-Weekly Drinker
4.211000E-01
Daily Drinker-vs-Occasional Drinker
4.872200E-01
Daily Drinker-vs-Social Drinker
8.603200E-01
Weekly Drinker-vs-Occasional Drinker
1.166210E-01
Weekly Drinker-vs-Social Drinker
3.891200E-01
Occasional Drinker-vs-Social Drinker
2.606200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.424300E-02
Normal-vs-Grade 2
1.967740E-02
Normal-vs-Grade 3
6.722900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.181600E-01
Grade 1-vs-Grade 3
5.234200E-02
Grade 1-vs-Grade 4
5.424300E-02
Grade 2-vs-Grade 3
3.095400E-01
Grade 2-vs-Grade 4
1.967740E-02
Grade 3-vs-Grade 4
6.722900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.770600E-01
Normal-vs-NonDiabetic
6.267000E-01
Diabetic-vs-NonDiabetic
3.011200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.099600E-01
Normal-vs-NoPancreatitis
7.335600E-01
Pancreatitis-vs-NoPancreatitis
3.844300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.896800E-01
Normal-vs-N1
6.310800E-01
N0-vs-N1
6.998400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.625980E-01
Normal-vs-TP53-NonMutant
6.629600E-01
TP53-Mutant-vs-TP53-NonMutant
1.788970E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
